United States Biotechnology & Medical Research

Kiniksa Pharmaceuticals Ltd (KNSA)

Track

Track

Kiniksa Pharmaceuticals experienced significant insider selling activity recently, totaling approximately 6.7 million dollars over the past quarter. Key executives, including the Chief Accounting Officer and various directors, executed these divestments. This trend follows a period of strong stock performance, with shares trading near their fifty-two-week highs ahead of the next scheduled earnings report.
Ticker: KNSA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kiniksa Pharmaceuticals Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Megna Michael R CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
474.75
Quantity 36,126 -21.3%
Value US$4,953,292
2.2
Megna Michael R Officer Officer
Transaction date
Proposed sale
Price
56.77
Quantity 93,819
Value US$661,007
3.2
Cole G Bradley Non-Executive Director
Transaction date
Sale
Price
231.69
Quantity 71,303 +1.4%
Value US$1,166,711
Tessari Eben Former Affiliate
Transaction date
Proposed sale
Price
79.74
Quantity 67,062
Value US$5,347,344
3.2
Cole G Bradley Director Non-Executive Director
Transaction date
Proposed sale
Price
81.43
Quantity 3,673
Value US$299,092
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
54.04
Quantity 21,097 -24.3%
Value US$1,140,082
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
53.52
Quantity 37,327 -30.1%
Value US$1,997,741
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
54.02
Quantity 48,565 -100.0%
Value US$2,623,481
Paolini John F. Officer Officer
Transaction date
Proposed sale
Price
53.71
Quantity 58,424
Value US$3,137,710
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
54.01
Quantity 2,141 -100.0%
Value US$115,635
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
54.01
Quantity 22,544 -100.0%
Value US$1,217,601
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
54.02
Quantity 51,750 -100.0%
Value US$2,795,535
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
52.02
Quantity 243,596 -82.5%
Value US$12,671,864
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
51.47
Quantity 113,673 -27.8%
Value US$5,850,749
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
50.43
Quantity 74,635 -15.4%
Value US$3,763,843
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
50.10
Quantity 13,099 -51.1%
Value US$656,260
Patel Sanj K Officer; Director Executive Director
Transaction date
Proposed sale
Price
51.60
Quantity 344,591
Value US$17,780,309
2.2
Megna Michael R CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
46.69
Quantity 6,625 -19.5%
Value US$309,321
Moat Ross CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
46.69
Quantity 1,703 -12.4%
Value US$79,513
Moat Ross Officer Officer
Transaction date
Proposed sale
Price
46.69
Quantity 1,703
Value US$79,513
2.2
Megna Michael R Officer Officer
Transaction date
Proposed sale
Price
46.69
Quantity 6,625
Value US$309,321
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
50.01
Quantity 7,278 -100.0%
Value US$363,973
Moat Ross CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
48.58
Quantity 2,367 -16.4%
Value US$114,989
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 6,901 -35.5%
Value US$345,050
2.5
Quart Barry D Director Non-Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 20,000
Value US$1,000,000
Patel Sanj K Officer; Director Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 219,591
Value US$10,979,550
Moat Ross Officer Officer
Transaction date
Proposed sale
Price
48.58
Quantity 2,367
Value US$114,989
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
46.24
Quantity 18,741 -60.8%
Value US$866,584
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
45.58
Quantity 17,981 -36.8%
Value US$819,574
Ragosa Mark Officer Officer
Transaction date
Proposed sale
Price
45.92
Quantity 36,722
Value US$1,686,179
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
45.92
Quantity 5,714 -8.5%
Value US$262,387
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
44.88
Quantity 22,223 -24.9%
Value US$997,368
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
44.20
Quantity 12,063 -11.9%
Value US$533,185
Paolini John F. Officer Officer
Transaction date
Proposed sale
Price
44.82
Quantity 40,000
Value US$1,792,970
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 2,690 -17.7%
Value US$121,050
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 110 -0.9%
Value US$4,950
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
43.72
Quantity 8,731 -41.9%
Value US$381,719
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
42.85
Quantity 9,114 -30.5%
Value US$390,535
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 2,602 -17.2%
Value US$117,142
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 2,602 -17.2%
Value US$117,142
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.27
Quantity 12,528 -50.0%
Value US$567,143
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.27
Quantity 12,528 -50.0%
Value US$567,143
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 830 -6.2%
Value US$37,350
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 830 -6.2%
Value US$37,350
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
41.89
Quantity 12,000 -38.6%
Value US$502,680
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
41.56
Quantity 12,048 -42.0%
Value US$500,715
2.5
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
41.51
Quantity 20,129 -61.6%
Value US$835,555
2.5
Quart Barry D Director Non-Executive Director
Transaction date
Proposed sale
Price
41.51
Quantity 58,889
Value US$2,444,530
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
41.49
Quantity 42,841 -58.0%
Value US$1,777,473
Ragosa Mark Officer Officer
Transaction date
Proposed sale
Price
41.49
Quantity 72,686
Value US$3,015,917
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
42.89
Quantity 200 -0.9%
Value US$8,578
Tessari Eben Officer Officer
Transaction date
Proposed sale
Price
42.89
Quantity 48,384
Value US$2,075,190
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
41.30
Quantity 11,825 -34.2%
Value US$488,372
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
40.08
Quantity 645 -1.8%
Value US$25,852
Tessari Eben Officer Officer
Transaction date
Proposed sale
Price
41.24
Quantity 12,470
Value US$514,225
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
40.94
Quantity 19,900 -39.0%
Value US$814,706
Paolini John F. CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
37.14
Quantity 82,542 -57.4%
Value US$3,065,610
Paolini John F. Officer Officer
Transaction date
Proposed sale
Price
37.14
Quantity 82,542
Value US$3,065,800
Ragosa Mark CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
41.00
Quantity 100 -0.3%
Value US$4,100
Ragosa Mark Officer Officer
Transaction date
Proposed sale
Price
41.00
Quantity 20,000
Value US$820,000
Ragosa Mark Officer Officer
Transaction date
Proposed sale
Price
41.00
Quantity 20,000
Value US$820,000
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
38.83
Quantity 97,390 -46.6%
Value US$3,781,654
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
38.77
Quantity 39,331 -26.0%
Value US$1,524,863
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
39.32
Quantity 22,314 -16.6%
Value US$877,386
Patel Sanj K CHAIRMAN & CEO Executive Director
Transaction date
Planned sale
Price
38.81
Quantity 98,934 -42.5%
Value US$3,839,629
2.2
Megna Michael R CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
39.31
Quantity 13,235 -32.9%
Value US$520,268
2.2
Megna Michael R CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
38.72
Quantity 37,255 -48.0%
Value US$1,442,514
Patel Sanj K Officer; Director Executive Director
Transaction date
Proposed sale
Price
38.90
Quantity 257,969
Value US$10,035,561
2.2
Megna Michael R Officer Officer
Transaction date
Proposed sale
Price
38.88
Quantity 50,490
Value US$1,962,914
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
37.99
Quantity 553 -1.9%
Value US$21,008
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
37.65
Quantity 11,815 -28.8%
Value US$444,835
Tessari Eben Officer Officer
Transaction date
Proposed sale
Price
37.66
Quantity 12,368
Value US$465,786
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
38.33
Quantity 42,000 -54.9%
Value US$1,609,860
Tessari Eben Officer Officer
Transaction date
Proposed sale
Price
38.33
Quantity 42,000
Value US$1,609,716
Tessari Eben CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
37.00
Quantity 356 -1.0%
Value US$13,172
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-03 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
36,126 -21.3%
474.75
US$4,953,292 		36,126 -21.3% 474.75 US$4,953,292
2026-09-03 2026-09-03 PrS Proposed sale
2.2
Megna Michael R

Officer

Officer
93,819
56.77
US$661,007 		93,819 56.77 US$661,007
2026-07-31 2026-07-29 S Sale
3.2
Cole G Bradley
Non-Executive Director
71,303 +1.4%
231.69
US$1,166,711 		71,303 +1.4% 231.69 US$1,166,711
2026-07-29 2026-07-29 PrS Proposed sale
Tessari Eben

Former Affiliate
67,062
79.74
US$5,347,344 		67,062 79.74 US$5,347,344
2026-07-29 2026-07-29 PrS Proposed sale
3.2
Cole G Bradley

Director

Non-Executive Director
3,673
81.43
US$299,092 		3,673 81.43 US$299,092
2026-05-05 2026-05-01 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
21,097 -24.3%
54.04
US$1,140,082 		21,097 -24.3% 54.04 US$1,140,082
2026-05-05 2026-05-01 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
37,327 -30.1%
53.52
US$1,997,741 		37,327 -30.1% 53.52 US$1,997,741
2026-05-01 2026-05-01 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
48,565 -100.0%
54.02
US$2,623,481 		48,565 -100.0% 54.02 US$2,623,481
2026-05-01 2026-05-01 PrS Proposed sale
Paolini John F.

Officer

Officer
58,424
53.71
US$3,137,710 		58,424 53.71 US$3,137,710
2026-04-30 2026-04-30 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
2,141 -100.0%
54.01
US$115,635 		2,141 -100.0% 54.01 US$115,635
2026-04-30 2026-04-29 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
22,544 -100.0%
54.01
US$1,217,601 		22,544 -100.0% 54.01 US$1,217,601
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
51,750 -100.0%
54.02
US$2,795,535 		51,750 -100.0% 54.02 US$2,795,535
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
243,596 -82.5%
52.02
US$12,671,864 		243,596 -82.5% 52.02 US$12,671,864
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
113,673 -27.8%
51.47
US$5,850,749 		113,673 -27.8% 51.47 US$5,850,749
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
74,635 -15.4%
50.43
US$3,763,843 		74,635 -15.4% 50.43 US$3,763,843
2026-04-29 2026-04-28 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
13,099 -51.1%
50.10
US$656,260 		13,099 -51.1% 50.10 US$656,260
2026-04-28 2026-04-28 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
344,591
51.60
US$17,780,309 		344,591 51.60 US$17,780,309
2026-04-13 2026-04-09 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
6,625 -19.5%
46.69
US$309,321 		6,625 -19.5% 46.69 US$309,321
2026-04-13 2026-04-09 PlS Planned sale
Moat Ross

CHIEF OPERATING OFFICER

Officer
1,703 -12.4%
46.69
US$79,513 		1,703 -12.4% 46.69 US$79,513
2026-04-09 2026-04-09 PrS Proposed sale
Moat Ross

Officer

Officer
1,703
46.69
US$79,513 		1,703 46.69 US$79,513
2026-04-09 2026-04-09 PrS Proposed sale
2.2
Megna Michael R

Officer

Officer
6,625
46.69
US$309,321 		6,625 46.69 US$309,321
2026-04-08 2026-04-06 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
7,278 -100.0%
50.01
US$363,973 		7,278 -100.0% 50.01 US$363,973
2026-04-08 2026-04-06 PlS Planned sale
Moat Ross

CHIEF OPERATING OFFICER

Officer
2,367 -16.4%
48.58
US$114,989 		2,367 -16.4% 48.58 US$114,989
2026-04-08 2026-04-06 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
6,901 -35.5%
50.00
US$345,050 		6,901 -35.5% 50.00 US$345,050
2026-04-06 2026-04-06 PrS Proposed sale
2.5
Quart Barry D

Director

Non-Executive Director
20,000
50.00
US$1,000,000 		20,000 50.00 US$1,000,000
2026-04-06 2026-04-06 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
219,591
50.00
US$10,979,550 		219,591 50.00 US$10,979,550
2026-04-06 2026-04-06 PrS Proposed sale
Moat Ross

Officer

Officer
2,367
48.58
US$114,989 		2,367 48.58 US$114,989
2026-03-11 2026-03-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
18,741 -60.8%
46.24
US$866,584 		18,741 -60.8% 46.24 US$866,584
2026-03-11 2026-03-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
17,981 -36.8%
45.58
US$819,574 		17,981 -36.8% 45.58 US$819,574
2026-03-09 2026-03-09 PrS Proposed sale
Ragosa Mark

Officer

Officer
36,722
45.92
US$1,686,179 		36,722 45.92 US$1,686,179
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
5,714 -8.5%
45.92
US$262,387 		5,714 -8.5% 45.92 US$262,387
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
22,223 -24.9%
44.88
US$997,368 		22,223 -24.9% 44.88 US$997,368
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
12,063 -11.9%
44.20
US$533,185 		12,063 -11.9% 44.20 US$533,185
2026-03-02 2026-03-02 PrS Proposed sale
Paolini John F.

Officer

Officer
40,000
44.82
US$1,792,970 		40,000 44.82 US$1,792,970
2026-02-12 2026-02-12 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,690 -17.7%
45.00
US$121,050 		2,690 -17.7% 45.00 US$121,050
2026-02-12 2026-02-10 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
110 -0.9%
45.00
US$4,950 		110 -0.9% 45.00 US$4,950
2026-02-11 2026-02-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
8,731 -41.9%
43.72
US$381,719 		8,731 -41.9% 43.72 US$381,719
2026-02-11 2026-02-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
9,114 -30.5%
42.85
US$390,535 		9,114 -30.5% 42.85 US$390,535
2026-02-04 2026-02-04 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,602 -17.2%
45.02
US$117,142 		2,602 -17.2% 45.02 US$117,142
2026-02-04 2026-02-04 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,602 -17.2%
45.02
US$117,142 		2,602 -17.2% 45.02 US$117,142
2026-02-04 2026-02-03 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
12,528 -50.0%
45.27
US$567,143 		12,528 -50.0% 45.27 US$567,143
2026-02-04 2026-02-03 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
12,528 -50.0%
45.27
US$567,143 		12,528 -50.0% 45.27 US$567,143
2026-02-04 2026-02-02 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
830 -6.2%
45.00
US$37,350 		830 -6.2% 45.00 US$37,350
2026-02-04 2026-02-02 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
830 -6.2%
45.00
US$37,350 		830 -6.2% 45.00 US$37,350
2026-01-09 2026-01-08 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
12,000 -38.6%
41.89
US$502,680 		12,000 -38.6% 41.89 US$502,680
2025-12-17 2025-12-15 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
12,048 -42.0%
41.56
US$500,715 		12,048 -42.0% 41.56 US$500,715
2025-12-17 2025-12-15 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
20,129 -61.6%
41.51
US$835,555 		20,129 -61.6% 41.51 US$835,555
2025-12-15 2025-12-15 PrS Proposed sale
2.5
Quart Barry D

Director

Non-Executive Director
58,889
41.51
US$2,444,530 		58,889 41.51 US$2,444,530
2025-12-10 2025-12-08 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
42,841 -58.0%
41.49
US$1,777,473 		42,841 -58.0% 41.49 US$1,777,473
2025-12-08 2025-12-08 PrS Proposed sale
Ragosa Mark

Officer

Officer
72,686
41.49
US$3,015,917 		72,686 41.49 US$3,015,917
2025-12-01 2025-11-26 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
200 -0.9%
42.89
US$8,578 		200 -0.9% 42.89 US$8,578
2025-11-26 2025-11-26 PrS Proposed sale
Tessari Eben

Officer

Officer
48,384
42.89
US$2,075,190 		48,384 42.89 US$2,075,190
2025-11-19 2025-11-17 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
11,825 -34.2%
41.30
US$488,372 		11,825 -34.2% 41.30 US$488,372
2025-11-19 2025-11-17 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
645 -1.8%
40.08
US$25,852 		645 -1.8% 40.08 US$25,852
2025-11-17 2025-11-17 PrS Proposed sale
Tessari Eben

Officer

Officer
12,470
41.24
US$514,225 		12,470 41.24 US$514,225
2025-11-14 2025-11-12 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
19,900 -39.0%
40.94
US$814,706 		19,900 -39.0% 40.94 US$814,706
2025-11-04 2025-10-31 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
82,542 -57.4%
37.14
US$3,065,610 		82,542 -57.4% 37.14 US$3,065,610
2025-10-31 2025-10-31 PrS Proposed sale
Paolini John F.

Officer

Officer
82,542
37.14
US$3,065,800 		82,542 37.14 US$3,065,800
2025-10-30 2025-10-28 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
100 -0.3%
41.00
US$4,100 		100 -0.3% 41.00 US$4,100
2025-10-28 2025-10-28 PrS Proposed sale
Ragosa Mark

Officer

Officer
20,000
41.00
US$820,000 		20,000 41.00 US$820,000
2025-10-28 2025-10-28 PrS Proposed sale
Ragosa Mark

Officer

Officer
20,000
41.00
US$820,000 		20,000 41.00 US$820,000
2025-10-22 2025-10-22 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
97,390 -46.6%
38.83
US$3,781,654 		97,390 -46.6% 38.83 US$3,781,654
2025-10-22 2025-10-21 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
39,331 -26.0%
38.77
US$1,524,863 		39,331 -26.0% 38.77 US$1,524,863
2025-10-22 2025-10-20 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
22,314 -16.6%
39.32
US$877,386 		22,314 -16.6% 39.32 US$877,386
2025-10-22 2025-10-20 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
98,934 -42.5%
38.81
US$3,839,629 		98,934 -42.5% 38.81 US$3,839,629
2025-10-22 2025-10-20 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
13,235 -32.9%
39.31
US$520,268 		13,235 -32.9% 39.31 US$520,268
2025-10-22 2025-10-20 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
37,255 -48.0%
38.72
US$1,442,514 		37,255 -48.0% 38.72 US$1,442,514
2025-10-20 2025-10-20 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
257,969
38.90
US$10,035,561 		257,969 38.90 US$10,035,561
2025-10-20 2025-10-20 PrS Proposed sale
2.2
Megna Michael R

Officer

Officer
50,490
38.88
US$1,962,914 		50,490 38.88 US$1,962,914
2025-10-16 2025-10-14 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
553 -1.9%
37.99
US$21,008 		553 -1.9% 37.99 US$21,008
2025-10-16 2025-10-14 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
11,815 -28.8%
37.65
US$444,835 		11,815 -28.8% 37.65 US$444,835
2025-10-14 2025-10-14 PrS Proposed sale
Tessari Eben

Officer

Officer
12,368
37.66
US$465,786 		12,368 37.66 US$465,786
2025-10-01 2025-09-29 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
42,000 -54.9%
38.33
US$1,609,860 		42,000 -54.9% 38.33 US$1,609,860
2025-09-29 2025-09-29 PrS Proposed sale
Tessari Eben

Officer

Officer
42,000
38.33
US$1,609,716 		42,000 38.33 US$1,609,716
2025-09-17 2025-09-15 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
356 -1.0%
37.00
US$13,172 		356 -1.0% 37.00 US$13,172
Explore more

More insider trading research around Kiniksa Pharmaceuticals Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America